The global registry of COVID-19 clinical trials: indicating the design of traditional Chinese medicine clinical trials

• 作者: Chen Zhao Hongcai Shang Manke Guan Mengzhu Zhao Ruijin Qiu Xiaoyu Zhang Xuxu Wei Yang Sun Yiyi Lin
• 来源期刊: TMR现代中药
• 学科: 医学
• 关键词: COVID-19 CLINICAL TRIAL REGISTER Data analysis
• 年，卷（期）: 2020,（3）
• 页码范围: 140-146
• 页数: 7页
• 分类号: R73

摘要

Objective:To analyze the registration information of Corona Virus Disease 2019(COVID-19)related clinical trials from all the clinical trial registry accepted by the International Committee of Medical Journal Editors(ICMJE).Methods:All the database of ICMJE-accepted clinical trial registry platform were searched for COVID-19 related clinical trials that registered from December 8,2019 to February 19,2020.Results:All the database totally contained data of 209 COVID-19 related clinical trials,including 66(31.6%)traditional Chinese medicine(TCM)related studies and 143(68.4%)non-TCM related studies.176(84.2%)clinical trials were registered in ChiCTR,as 33(15.8%)were registered in ClinicalTrials.gov.There were 152(72.7%)intervention trials,including 9(4.3%in total)preventive trials,136(65.1%in total)therapeutic trials and 7(3.3%in total)convalescent trials.Conclusion:At the present stage,clinical studies are still aiming at exploring the effective treatment of COVID-19,and the existing treatments need more high-quality clinical evidence supporting.Traditional Chinese medicine may have played an important role in all stages of the epidemic preventing and control,and the enthusiasm of carrying out scientific research has also been greatly improved.The relevant policies of clinical trial registration should be popularized among researchers,including traditional Chinese medicine researchers.And the methodological quality of clinical trials’design urges improving.